PRAX – praxis precision medicines, inc. (US:NASDAQ)
Stock Stats
News
Praxis Precision Medicines (NASDAQ:PRAX) was given a new $304.00 price target on by analysts at Needham & Company LLC.
Praxis Precision Medicines (NASDAQ:PRAX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at BTIG Research.
Praxis Precision Medicines (NASDAQ:PRAX) had its "underperform" rating reaffirmed by analysts at Wedbush.
Form 4 Praxis Precision Medicin For: Nov 20 Filed by: Nemiroff Alex
Form 4 Praxis Precision Medicin For: Nov 14 Filed by: Kelly Timothy Edwin
Form 4 Praxis Precision Medicin For: Nov 20 Filed by: Mastrocola Lauren
Form 144 Praxis Precision Medicin Filed by: Nemiroff Alex
Form 144 Praxis Precision Medicin Filed by: Mastrocola Lauren
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.